Mobilization of peripheral blood progenitor cells with G-CSF alone in lymphoma patients: steady-state circulating progenitor cell count predicts the autograft yield.
نویسندگان
چکیده
1994. p. 157. 2. Kulozik AE. -thalassaemia: molecular pathogenesis and clinical variability. Eur J Pediatr 1992; 151:78-84. 3. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215. 4. Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of -thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet 1990; 336:834-7. 5. Roldán A, Gutiérrez M, Cygler A, et al. Molecular characterization of -thalassemia genes in an Argentine population. Am J Hematol 1997; 54:179-82. 6. Soria NW, Tulián CL, Plassa F, Roth GA. -thalassemia and hemoglobin types in Argentina: determination of most frequent mutations. Am J Hematol 1997; 54:160-3. 7. Noguera N, Bragós I, Morisoli L, Milani A. Screening for hemoglobinopathies in neonates in Argentina. Haematologica 1999; 84:387-9. 8. Schiliró G, Di Gregorio F, Samperi P, et al. Genetic heterogeneity of thalassemia in Southeast Sicily. Am J Hematol 1995; 48:5-11. 9. Cao A, Gossens M, Pirastu M. -thalassaemia mutations in Mediterranean populations. Br J Haematol 1989; 71:309-12. 10. Vania A, Gentiloni Silverj F, Fruscella R, Plantamura M, Cianciulli P, Ballati G. Thalassemic syndromes in Latium: epidemiological evaluation. Haematologica 1998; 83:525-32.
منابع مشابه
Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization
The combination of filgrastim (G-CSF) and plerixafor is currently approved for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin lymphoma and multiple myeloma undergoing autologous peripheral blood hematopoietic cell transplantation. However, chemotherapy and G-CSF-based mobilization remains a widely used strategy for peripheral blood progenitor cell collection. In this ...
متن کاملEDUCATION SESSION 12: CELLULAR THERAPY New Strategies for Blood Progenitor Cell Mobilization
After 20 years of painstaking clinical trials in peripheral blood stem cell mobilization and transplantation, a large database has accumulated on how to mobilize and to collect factors affecting mobilization, the progenitor cell dose effect on haemopoietic recovery, and even ambulatory transplant (To et al, 1997). Currently an increasing number of allogeneic transplants and most autologous tran...
متن کاملبررسی تاثیر ریتم شبانه روزی بر ترشح آدرنالین و نور آدرنالین و ارتباط ان با میزان موبیلیزاسیون سلول های بنیادی CD34
Hematopoietic stem cells (HSCs), which have the ability to differentiate into various types of blood cell lines, are usually separate from the bone marrow. But these cells are also present in a small amount in the peripheral blood, and their amounts increase in blood following injection of G-CSF. However, the mechanism involved in moving HSCs under the influence of G-CSF is unknown. The aim of ...
متن کاملPotentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3.
Granulocyte colony-stimulating factor (G-CSF) as a single agent is increasingly used for the mobilization of peripheral blood progenitor cells (PBPCs) for stem cell transplantation. In patients with perturbed hematopoiesis the mobilizing capacity of G-CSF alone may be inadequate. We have shown in rhesus monkeys that interleukin-3 (IL-3) pretreatment markedly potentiated the increase in PBPC num...
متن کاملPeripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
Peripheral blood progenitor cells (PBPC) can be mobilized using cytotoxic chemotherapy and cytokines. There is a substantial variability in the yield of hematopoietic progenitor cells between patients. We were looking for predictive parameters indicating a patient's response to a given mobilization regimen. Multiparameter flow-cytometry analysis and clonogenic assays were used to examine the he...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Haematologica
دوره 85 1 شماره
صفحات -
تاریخ انتشار 2000